INGN Overview

Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.

Wall Street analysts forecast INGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INGN is13.00 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Inogen Inc revenue for the last quarter amounts to 81.72M USD, increased 2.05

Inogen Inc. EPS for the last quarter amounts to -0.26 USD, decreased -36.59

Inogen Inc (INGN) has 753 emplpoyees as of April 20 2026.

Today INGN has the market capitalization of 185.72M USD.